We are live on ! Find out more
VSTM icon

Verastem
VSTM

109 hedge funds and large institutions have $218M invested in Verastem in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 20 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 20

107% more call options, than puts

Call options by funds: $937K | Put options by funds: $452K

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

11.64% more ownership

Funds ownership: 84.05% → 95.69% (+12%)

10% more funds holding

Funds holding: 99 → 109 (+10)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

16% less capital invested

Capital invested by funds: $261M → $218M (-$42.7M)

Holders
109
Holders Change
+10
Holders Change %
+10.1%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
28
Increased
47
Reduced
20
Closed
17
Calls
$937K
Puts
$452K
Net Calls
+$485K
Net Calls Change
+$194K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$14.3M
2
AC
Armistice Capital
New York
+$13.4M
3
State Street
State Street
Massachusetts
+$9.02M
4
BI
BVF Inc
California
+$8.17M
5
FCMV
Foresite Capital Management VI
California
+$8M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$17.3M
2
Marshall Wace
Marshall Wace
United Kingdom
-$12.3M
3
OCA
Octagon Capital Advisors
New York
-$10.4M
4
RA
Rosalind Advisors
Ontario, Canada
-$3.76M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
101
EverSource Wealth Advisors
Alabama
$1.87K -$75 -12 -3%
A
102
AlphaQuest
New York
$1.69K +$2.56K +408 New
Nisa Investment Advisors
103
Nisa Investment Advisors
Missouri
$1.52K -$5.58K -890 -71%
GI
104
GAMMA Investing
California
$681 -$2.39K -382 -70%
SS
105
SBI Securities
Japan
$415 +$614 +98 +4,900%
National Bank of Canada
106
National Bank of Canada
Quebec, Canada
$154 +$232 +37 New
US Bancorp
107
US Bancorp
Minnesota
$95 – – –
HI
108
Harbour Investments
Wisconsin
$58 – – –
GRP
109
Global Retirement Partners
California
$33 +$50 +8 New
EWM
110
Evermay Wealth Management
Virginia
$25 – – –
O
111
OrbiMed
New York
– -$17.3M -2,862,448 Closed
OCA
112
Octagon Capital Advisors
New York
– -$10.4M -1,720,000 Closed
CC
113
Casdin Capital
New York
– -$3.62M -600,000 Closed
IHAM
114
Integral Health Asset Management
New York
– -$3.02M -500,000 Closed
SCM
115
Superstring Capital Management
New York
– -$2.03M -336,363 Closed
WP
116
Woodline Partners
California
– -$474K -78,676 Closed
PAMP
117
Polar Asset Management Partners
Ontario, Canada
– -$300K -49,800 Closed
CF
118
Corebridge Financial
Texas
– -$115K -19,004 Closed
Verition Fund Management
119
Verition Fund Management
Connecticut
– -$69.7K -11,565 Closed
HF
120
HRT Financial
New York
– -$68K -11,402 Closed
CCM
121
Coldstream Capital Management
Washington
– -$3.71K -615 Closed
SSG
122
Summit Securities Group
New York
– -$639 -106 Closed
PWA
123
Physician Wealth Advisors
Utah
– -$573 -95 Closed
S
124
SignatureFD
Georgia
– -$271 -45 Closed
TWD
125
True Wealth Design
Ohio
– -$139 -23 Closed
2 3 4
5
6

VSTM Hedge Fund Activity: Q2 2025 in Review

109 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q2 2025, worth a combined $218M — down 16% from $261M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VSTM positions and 17 closed out — a net gain of 11 holders — while 47 added to existing stakes and 20 trimmed.

The largest buyer was J. Goldman & Co, adding an estimated $14.3M. The largest seller was OrbiMed, exiting entirely with an estimated $17.3M sold.

  • 109 institutional investors held Verastem (VSTM) as of Q2 2025, up from 99 in Q1 2025.
  • Funds reported $218M of Verastem stock for Q2 2025, down 16% quarter-over-quarter.
  • 28 funds opened new Verastem positions in Q2 2025 and 17 closed out, a net change of +11 holders.
  • The largest Verastem buyer in Q2 2025 was J. Goldman & Co, an estimated $14.3M added.
  • The largest Verastem seller in Q2 2025 was OrbiMed, an estimated $17.3M sold.

Based on aggregated 13F filings for Q2 2025.